Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).

Bhan V, Cantor WJ, Yan RT, Mehta SR, Morrison LJ, Heffernan M, Fitchett D, Džavík V, Ducas J, Borgundvaag B, Cohen EA, Goodman SG, Yan AT.

Am Heart J. 2012 Sep;164(3):343-50. doi: 10.1016/j.ahj.2012.05.022. Epub 2012 Aug 17.

PMID:
22980300
2.

Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).

Tan NS, Goodman SG, Cantor WJ, Tan MK, Yan RT, Bagnall AJ, Mehta SR, Fitchett D, Strauss BH, Yan AT; TRANSFER-AMI Investigators..

Am J Cardiol. 2014 Oct 1;114(7):955-61. doi: 10.1016/j.amjcard.2014.05.069. Epub 2014 Jul 16.

PMID:
25118119
3.

Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.

Russo JJ, Goodman SG, Cantor WJ, Fitchett D, Heffernan M, Borgundvaag B, Ducas J, Cohen EA, Džavik V, Mehta SR, Buller CE, Yan AT; TRANSFER-AMI investigators..

Heart. 2014 Jun;100(11):873-80. doi: 10.1136/heartjnl-2013-305231. Epub 2014 Jan 21.

PMID:
24449716
4.

Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).

Cantor WJ, Fitchett D, Borgundvaag B, Heffernan M, Cohen EA, Morrison LJ, Ducas J, Langer A, Mehta S, Lazzam C, Schwartz B, Dzavik V, Goodman SG.

Am Heart J. 2008 Jan;155(1):19-25. Epub 2007 Oct 25. Erratum in: Am Heart J. 2008 Feb;155(2):323. Ducas, John [added].

PMID:
18082484
5.

Efficacy of Early Invasive Management After Fibrinolysis for ST-Segment Elevation Myocardial Infarction in Relation to Initial Troponin Status.

Tan NS, Goodman SG, Cantor WJ, Russo JJ, Borgundvaag B, Fitchett D, Džavík V, Tan MK, Elbarouni B, Lavi S, Bagai A, Heffernan M, Ko DT, Yan AT.

Can J Cardiol. 2016 Oct;32(10):1221.e11-1221.e18. doi: 10.1016/j.cjca.2016.01.010. Epub 2016 Jan 21.

PMID:
26975225
6.

Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).

Yan AT, Yan RT, Cantor WJ, Borgundvaag B, Cohen EA, Fitchett DH, Dzavik V, Ducas J, Tan M, Casanova A, Goodman SG; TRANSFER-AMI Investigators..

Eur Heart J. 2011 Aug;32(16):1994-2002. doi: 10.1093/eurheartj/ehr008. Epub 2011 Feb 8.

PMID:
21307037
7.

Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.

Elbarouni B, Cantor WJ, Ducas J, Borgundvaag B, Džavík V, Heffernan M, Buller CE, Langer A, Goodman SG, Yan AT; TRANSFER-AMI Trial Investigators..

Can J Cardiol. 2014 Dec;30(12):1555-61. doi: 10.1016/j.cjca.2014.09.001. Epub 2014 Sep 4.

PMID:
25475460
8.

Efficacy and safety of a routine early invasive strategy in relation to time from symptom onset to fibrinolysis (a subgroup analysis of TRANSFER-AMI).

Russo JJ, Goodman SG, Cantor WJ, Tan MK, Borgundvaag B, Fitchett D, Džavík V, Yan RT, Graham JJ, Mehta SR, Yan AT; TRANSFER-AMI Investigators..

Am J Cardiol. 2015 Apr 15;115(8):1005-12. doi: 10.1016/j.amjcard.2015.01.533. Epub 2015 Jan 31.

PMID:
25711435
9.

Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial.

Lavi S, Cantor WJ, Casanova A, Tan MK, Yan AT, Džavík V, Fitchett D, Cohen EA, Borgundvaag B, Heffernan M, Ducas J, Goodman SG.

Am Heart J. 2012 Feb;163(2):176-81.e2. doi: 10.1016/j.ahj.2011.10.015.

PMID:
22305834
11.

The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction.

Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Santopinto J, Corsini G, Terrosu P, Joulain F.

J Thromb Thrombolysis. 2005 Jun;19(3):155-61.

PMID:
16082602
12.

Routine early angioplasty after fibrinolysis for acute myocardial infarction.

Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG; TRANSFER-AMI Trial Investigators..

N Engl J Med. 2009 Jun 25;360(26):2705-18. doi: 10.1056/NEJMoa0808276.

13.

Long-term follow-up of early versus delayed invasive approach after fibrinolysis in acute myocardial infarction.

Clever YP, Cremers B, Link A, Böhm M, Scheller B.

Circ Cardiovasc Interv. 2011 Aug;4(4):342-8. doi: 10.1161/CIRCINTERVENTIONS.111.962316. Epub 2011 Jun 28.

14.

Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials.

Bagai A, Tan M, Di Mario C, Halvorsen S, Cantor WJ, Le May MR, Fernandez-Aviles F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sánchez PL, Westerhout CM, Goodman SG, Yan AT.

Am Heart J. 2014 Nov;168(5):757-65. doi: 10.1016/j.ahj.2014.07.027. Epub 2014 Aug 7.

PMID:
25440805
15.

Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.

D'Ascenzo F, Gonella A, Quadri G, Longo G, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Gaita F, Sheiban I.

Am J Cardiol. 2011 Mar 1;107(5):651-4. doi: 10.1016/j.amjcard.2010.10.038. Epub 2010 Dec 31.

PMID:
21195375
16.

Gender differences in the outcome of cardiac interventions.

Tillmanns H, Waas W, Voss R, Grempels E, Hölschermann H, Haberbosch W, Waldecker B.

Herz. 2005 Aug;30(5):375-89. Review. English, German.

PMID:
16132240
17.

Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group..

Arch Intern Med. 2007 Jul 9;167(13):1353-9.

PMID:
17620527
19.

Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.

Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, Nyman K, Nammas W, Airaksinen KE, Karjalainen PP.

J Invasive Cardiol. 2012 Mar;24(3):104-8.

20.

[Prognosis after acute coronary syndrome. Lack of difference according to the sex].

Bounhoure JP, Farah B, Fajadet J, Marco J.

Bull Acad Natl Med. 2004;188(3):383-97; discussion 397-9. French.

PMID:
15584651

Supplemental Content

Support Center